Table 2.
Distribution of clinical management before and after the MRVP test in patients in the ward
| Test results | n | Antiviral treatment | Antibiotic treatment | ||||
|---|---|---|---|---|---|---|---|
| Empirically treated* | Postresult treatment | Empirically treated* | Postresult treatment | ||||
| Continued† | Discontinued† | Continued† | Discontinued† | ||||
| Hospitalized patients | |||||||
| Negative | 62 | 15(24.2) | 5(33.3) | 10(66.7) | 41(66.1) | 35(85.4) | 6(14.6) |
| Positive noninfluenza | 10 | 4(40.0) | 0(0) | 4(100) | 7(70.0) | 5(71.4) | 2(28.6) |
| Positive influenza | 17 | 7(41.2) | 7(100) | 0(0) | 12(70.6) | 9(75.0) | 3(25.0) |
| Patients diagnosed in the emergency room | |||||||
| Negative | 31 | 8(25.8) | 1(12.5) | 7(87.5) | 22(70.9) | 17(77.2) | 5(22.7) |
| Positive noninfluenza | 22 | 7(31.8) | 2(28.6) | 5(71.4) | 11(50.0) | 7(63.6) | 4(36.4) |
| Positive influenza | 44 | 16(36.4) | 14(87.5) | 2(12.5) | 19(43.2) | 13(68.4) | 6(31.6) |
NOTE. Values are n(%) or as otherwise indicated.
MRVP, multiplex reverse transcription polymerase chain reaction.
*
Proportion within the test result group.
†
Proportion within the empirically treated group.